Outcomes of a Disease-management Program for Patients with Recent Osteoporotic Fracture

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2006 Mar 30

PMID 16570119

Citations 11

Authors

M Che

B Ettinger

J Liang

A R Pressman

J Johnston

Affiliations

Soon will be listed here.

Abstract

Introduction: The purpose of this study was to evaluate outcomes of a disease-management program designed to increase rates of bone-mineral-density (BMD) testing and initiation of osteoporosis medication among patients with a recent osteoporotic fracture.

Study Design: We identified 744 consecutive patients aged>or=55 years who were seen at either of 2 of 14 Kaiser Permanente medical facilities in Northern California (KPNC) after sustaining a fracture of the hip, spine, wrist, or humerus between April 2003 and May 2004. These patients were invited to participate in a study of the Fragile Fracture Management Program, whose protocol used fracture-risk assessment tools to determine treatment recommendations. Postfracture care of study participants was compared with usual postfracture care received by osteoporotic-fracture patients at 12 other KPNC facilities.

Results: Of the 744 patients who were invited to participate in the study, 293 (39%) agreed to participate, and 169 (23%) completed the evaluation. Of these 169 patients (127 women, 42 men), 65 (51%) of the women and 7 (17%) of the men qualified for drug treatment; of these 72 patients, 6 (86%) of the men and 41 (63%) of the women accepted the offered treatment. At the two study locations, rates of care (BMD testing or prescribing osteoporosis medication) were about twice as high as rates of usual postfracture care observed at 12 other medical centers in KPNC.

Conclusions: Compared with patients who received usual care for osteoporotic fracture, patients participating in a postfracture disease management program had substantially higher rates of medical attention given for osteoporosis; however, the overall yield of the program was low. This low uptake rate was related to factors not previously appreciated: many patients refused participation in the program; a high proportion of younger women-and men of all ages-did not qualify for treatment; and treatment was refused by one in three study-qualified women and by one in seven study-qualified men. Additional efforts are needed to overcome patient barriers to improved osteoporosis evaluation, treatment and participation in postfracture programs.

Citing Articles

Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis.

Ali A, Huszti E, Noordin S, Ali U, Sale J Osteoporos Int. 2024; 35(9):1497-1511.

PMID: 38740589 DOI: 10.1007/s00198-024-07078-5.

Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021.

Corrao G, Biffi A, Porcu G, Ronco R, Adami G, Alvaro R Front Endocrinol (Lausanne). 2023; 14:1137671.

PMID: 37143730 PMC: 10151776. DOI: 10.3389/fendo.2023.1137671.

Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.

Wozniak L, Johnson J, McAlister F, Beaupre L, Bellerose D, Rowe B Osteoporos Int. 2016; 28(1):219-229.

PMID: 27423660 PMC: 5206259. DOI: 10.1007/s00198-016-3693-5.

Osteoporosis screening and treatment among veterans with recent fracture after implementation of an electronic consult service.

Lee R, Lyles K, Pearson M, Barnard K, Colon-Emeric C Calcif Tissue Int. 2014; 94(6):659-64.

PMID: 24699797 PMC: 4058771. DOI: 10.1007/s00223-014-9849-4.

Osteoporosis, frailty and fracture: implications for case finding and therapy.

van den Bergh J, van Geel T, Geusens P Nat Rev Rheumatol. 2012; 8(3):163-72.

PMID: 22249162 DOI: 10.1038/nrrheum.2011.217.

References

Black D, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni M . An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001; 12(7):519-28. DOI: 10.1007/s001980170072. View

Snyder J, Malaskovitz J, Griego J, Persson J, Flatt K . Quality improvement and cost reduction realized by a purchaser through diabetes disease management. Dis Manag. 2004; 6(4):233-41. DOI: 10.1089/109350703322682540. View

Newman E, Ayoub W, STARKEY R, Diehl J, Wood G . Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int. 2003; 14(2):146-51. DOI: 10.1007/s00198-002-1336-5. View

Ettinger B, Hillier T, Pressman A, Che M, Hanley D . Simple computer model for calculating and reporting 5-year osteoporotic fracture risk in postmenopausal women. J Womens Health (Larchmt). 2005; 14(2):159-71. DOI: 10.1089/jwh.2005.14.159. View

Ross P, Davis J, Epstein R, Wasnich R . Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991; 114(11):919-23. DOI: 10.7326/0003-4819-114-11-919. View

Sidwell A, Wilkinson T, Hanger H . Secondary prevention of fractures in older people: evaluation of a protocol for the investigation and treatment of osteoporosis. Intern Med J. 2004; 34(3):129-32. DOI: 10.1111/j.1444-0903.2004.00554.x. View

Hawker G, Ridout R, Ricupero M, Jaglal S, Bogoch E . The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients. Osteoporos Int. 2003; 14(2):171-8. DOI: 10.1007/s00198-003-1377-4. View

Lindsay R, Silverman S, Cooper C, Hanley D, Barton I, Broy S . Risk of new vertebral fracture in the year following a fracture. JAMA. 2001; 285(3):320-3. DOI: 10.1001/jama.285.3.320. View

Siris E, Bilezikian J, Rubin M, Black D, Bockman R, Bone H . Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab. 2003; 88(8):3482-6. DOI: 10.1210/jc.2003-030568. View

10.

Kanis J, Johnell O, Oden A, Borgstrom F, Johansson H, De Laet C . Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden. Osteoporos Int. 2004; 16(1):6-14. DOI: 10.1007/s00198-004-1623-4. View

11.

Boulet L, Thivierge R, Amesse A, Nunes F, Francoeur S, Collet J . Towards excellence in asthma management (TEAM): a populational disease-management model. J Asthma. 2002; 39(4):341-50. DOI: 10.1081/jas-120002292. View

12.

Freedman K, Kaplan F, Bilker W, Strom B, Lowe R . Treatment of osteoporosis: are physicians missing an opportunity?. J Bone Joint Surg Am. 2000; 82(8):1063-70. DOI: 10.2106/00004623-200008000-00001. View

13.

Cuddihy M, Amadio P, Gabriel S, Pankratz V, Kurland R, Melton 3rd L . A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int. 2004; 15(9):695-700. DOI: 10.1007/s00198-004-1597-2. View

14.

Simonelli C, Killeen K, Mehle S, Swanson L . Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc. 2002; 77(4):334-8. DOI: 10.4065/77.4.334. View

15.

Hajcsar E, Hawker G, Bogoch E . Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ. 2000; 163(7):819-22. PMC: 80503. View

16.

. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285(6):785-95. DOI: 10.1001/jama.285.6.785. View

17.

Klotzbuecher C, Ross P, Landsman P, Abbott 3rd T, Berger M . Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000; 15(4):721-39. DOI: 10.1359/jbmr.2000.15.4.721. View

18.

GAULT M, Longerich L, Harnett J, Wesolowski C . Predicting glomerular function from adjusted serum creatinine. Nephron. 1992; 62(3):249-56. DOI: 10.1159/000187054. View